The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia
The program gives eligible adults a telehealth pathway built around licensed doctor review, individualized treatment planning, ongoing clinical support, and coordination with licensed pharmacy partners
GLP-1 and GIP are already familiar from semaglutide and tirzepatide
Funding This work was supported by the National Natural Science Foundation of China (81400288, 81573244), Hubei Provincial Natural Science Foundation (2022CFB453), Foundation of Health Commission of Hubei (WJ2021M061), the Natural Science Foundation of the Bureau of Science and Technology of Shiyan City (grant no
Oshima, K
When compared with degludec in the SURPASS 3 trial, GI side effects were more common in the tirzepatide group, but hypoglycaemia was more common in people treated with degludec (12% versus 7%)